Get started
Author

Jonas Fullin

Observed name: Fullin, Jonas
ORCID: 0009-0009-8109-3790
Observed ORCID: 0009-0009-8109-3790
OpenAlex ID: A5018849584
Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling
2022 · Francisco Caiado, Larisa V. Kovtonyuk, et al. · Blood · 168
PDF
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells
2024 · Jan Mueller, Roman R Schimmer, et al. · EMBO Molecular Medicine · 36
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
2022 · Roman R. Schimmer, Larisa V. Kovtonyuk, et al. · Blood Advances · 35
PDF
Inhibitors of Bcl-2 and Bruton’s tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models
2021 · Katrin Bertram, Peter John Leary, et al. · Leukemia · 28
PDF
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis
2025 · Jonas Fullin, Ebru Topçu, et al. · Leukemia · 11
PDF
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al. · Cancer Research · 9
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease
2026 · Roman R. Schimmer, Nancy Klemm, et al. · Blood · 6
Fas ( CD95 ) expression in adipocytes contributes to diet‐induced obesity
2024 · Stephan Wueest, Chiara Scaffidi, et al. · Obesity · 4
Expression of p53 in human adipose tissue correlates positively with FAS and BMI
2024 · Stephan Wueest, Chiara Scaffidi, et al. · International Journal of Obesity · 3
PDF
TP53 Deficiency in AML Confers Resistance to CAR T-Cells That Can be Overcome By Targeting the Cholesterol or Wnt Pathways
2023 · Jan Mueller, Roman Schimmer, et al. · Blood · 3
The Pathogenesis of Therapy-Related Myeloid Neoplasms from TP53-Mutant Clonal Hematopoiesis
2024 · Jonas Fullin, Ebru Topçu, et al. · Blood · 1
Somatic TP53 Mutations Rescue the Hematopoietic Stem and Progenitor Cell Defect at the Expense of Increased Risk for Myeloid Malignancies in ERCC6L2-Associated Inherited Bone Marrow Failure Syndrome
2024 · Roman R. Schimmer, Nancy Klemm, et al. · Blood · 1
PDF
Modelling the Evolution of Clonal Hematopoiesis to Myeloid Malignancies Under the Selective Pressure of Anti-Cancer Therapy
2024 · Christian Koch, Jonas Fullin, et al. · Blood · 1
PDF
Tet2-Clonal Hematopoiesis Promotes Whereas Dnmt3a-CH Inhibits Breast Cancer Progression During Aging
2026 · Nagihan G. Gonullu, Karolina A. Zielinska, et al. · bioRxiv (Cold Spring Harbor Laboratory)
The Pathogenesis of Therapy-Related Myeloid Neoplasms from $\textit{TP53-}$Mutant Clonal Hematopoiesis
2026 · Fullin, Jonas · Zurich Open Repository and Archive (University of Zurich)
Data from The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al.
Figure S3 from The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al.
Figure S5 from The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al.
Figure S1 from The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al.
Figure S4 from The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al.
Figure S2 from The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect
2025 · Nancy Klemm, Roman R. Schimmer, et al.
Works count: 21
Citation count: 306
H-index: 6
I10-index: 5
Year
Topic
Type